Liquidia Co. (NASDAQ:LQDA) Shares Bought by Rhumbline Advisers

Rhumbline Advisers grew its stake in shares of Liquidia Co. (NASDAQ:LQDA) by 12.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 80,164 shares of the company’s stock after acquiring an additional 8,871 shares during the period. Rhumbline Advisers owned about 0.10% of Liquidia worth $962,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Patient Square Capital LP bought a new position in shares of Liquidia in the 1st quarter worth about $105,942,000. Vanguard Group Inc. lifted its position in shares of Liquidia by 1.5% in the 1st quarter. Vanguard Group Inc. now owns 2,887,274 shares of the company’s stock worth $42,587,000 after buying an additional 43,352 shares during the last quarter. Kynam Capital Management LP lifted its position in shares of Liquidia by 34.9% in the 4th quarter. Kynam Capital Management LP now owns 2,698,324 shares of the company’s stock worth $32,461,000 after buying an additional 698,324 shares during the last quarter. Farallon Capital Management LLC bought a new position in shares of Liquidia in the 1st quarter worth about $30,311,000. Finally, Vestal Point Capital LP bought a new position in shares of Liquidia in the 4th quarter worth about $12,331,000. 64.54% of the stock is owned by institutional investors and hedge funds.

Liquidia Trading Down 3.1 %

LQDA stock opened at $9.95 on Monday. Liquidia Co. has a 52 week low of $5.71 and a 52 week high of $16.99. The company has a market capitalization of $760.32 million, a price-to-earnings ratio of -6.38 and a beta of 0.22. The firm’s 50-day moving average is $10.75 and its two-hundred day moving average is $12.53.

Liquidia (NASDAQ:LQDA) last released its quarterly earnings results on Wednesday, August 7th. The company reported ($0.37) EPS for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.02). Liquidia had a negative return on equity of 183.57% and a negative net margin of 755.46%. The company had revenue of $3.66 million for the quarter, compared to the consensus estimate of $7.92 million. On average, equities research analysts predict that Liquidia Co. will post -1.69 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have recently issued reports on LQDA. BTIG Research reduced their price target on shares of Liquidia from $29.00 to $25.00 and set a “buy” rating on the stock in a research report on Monday, August 19th. Bank of America cut their price objective on shares of Liquidia from $24.00 to $23.00 and set a “buy” rating on the stock in a research report on Tuesday, August 20th. Oppenheimer started coverage on shares of Liquidia in a research report on Tuesday, June 25th. They issued a “market perform” rating on the stock. HC Wainwright cut their price objective on shares of Liquidia from $32.00 to $29.00 and set a “buy” rating on the stock in a research report on Tuesday, August 20th. Finally, Raymond James upgraded shares of Liquidia from an “outperform” rating to a “strong-buy” rating in a research report on Monday, August 19th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $23.14.

Insider Transactions at Liquidia

In other news, CEO Roger Jeffs sold 8,053 shares of Liquidia stock in a transaction that occurred on Friday, July 12th. The shares were sold at an average price of $12.53, for a total value of $100,904.09. Following the transaction, the chief executive officer now owns 818,932 shares of the company’s stock, valued at approximately $10,261,217.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CEO Roger Jeffs sold 8,053 shares of Liquidia stock in a transaction that occurred on Friday, July 12th. The shares were sold at an average price of $12.53, for a total value of $100,904.09. Following the transaction, the chief executive officer now owns 818,932 shares of the company’s stock, valued at approximately $10,261,217.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Caligan Partners Lp acquired 150,000 shares of the stock in a transaction dated Friday, August 30th. The stock was acquired at an average cost of $9.51 per share, for a total transaction of $1,426,500.00. Following the purchase, the director now directly owns 6,994,997 shares in the company, valued at $66,522,421.47. The disclosure for this purchase can be found here. Insiders have sold 21,422 shares of company stock valued at $256,998 in the last quarter. Insiders own 31.60% of the company’s stock.

Liquidia Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).